Dermatol. praxi. 2018;12(4):182-185 | DOI: 10.36290/der.2018.043

Current perspective on treating herpes zoster and postherpetic neuralgia

MUDr. Marek Pieran
Ambulance pro léčbu chronické bolesti při Klinice anestezie a resuscitace FN Olomouc

Postherpetic neuralgia (PHN) is a relatively frequent and stubborn complaint. The treatment is difficult given the irreversiblepathophysiological and anatomical changes in the neural structures, inadequate effect, and questionable tolerability to thetreatment recommended. The article summarizes the current options of analgesia and evaluation of their success rates in thecontext of IASP (International Association for the Study of Pain) experts’ recommendations.

Keywords: pain management, herpes zoster, postherpetic neuralgia

Received: June 17, 2018; Accepted: July 18, 2018; Published: December 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pieran M. Current perspective on treating herpes zoster and postherpetic neuralgia. Dermatol. praxi. 2018;12(4):182-185. doi: 10.36290/der.2018.043.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Yawn B, Gilden P. The global epidemiology of herpes zoster. Neurology, 2013, 81.10: 928-930. Go to original source... Go to PubMed...
    2. Yawn B, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. In: Mayo Clinic Proceedings. Elsevier, 2007. p. 1341-1349. Go to original source...
    3. Gauthier A, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiology & Infection, 2009, 137.1: 38-47. Go to original source... Go to PubMed...
    4. Van Wijck A JM, et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. The Lancet, 2006, 367.9506: 219-224. Go to original source... Go to PubMed...
    5. Petersen KL, Rowbotham MC. Natural history of sensory function after herpes zoster. Pain, 2010, 150.1: 83-92. Go to original source... Go to PubMed...
    6. Watson CPN, et al. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain, 1991, 44.2: 105-117. Go to original source...
    7. Haanpää M, Hietaharju A. Treating herpes zoster and postherpetic neuralgia. Pain Clin Updates, 2015, 23.4: 1-8.
    8. Chen N, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews, 2014, 2. Go to original source... Go to PubMed...
    9. Dworkin RH, et al. A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. PAIN(R), 2009, 142.3: 209-217. Go to original source...
    10. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: A randomized, double-blind, placebo-controlled trial. Journal of pain and symptom management, 1997, 13.6: 327-331. Go to original source... Go to PubMed...
    11. Chen N, et al. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev, 2010, 12. Go to original source... Go to PubMed...
    12. Schmader KE, et al. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clinical Infectious Diseases, 2012, 55.10: 1320-1328. Go to original source... Go to PubMed...
    13. Finnerup NB, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. The Lancet Neurology, 2015, 14.2: 162-173. Go to original source... Go to PubMed...
    14. Doležal T, et al. Metodické pokyny pro farmakoterapii bolesti. Bolest, 2009, 12.Suppl 2: 24-27.
    15. Haanpää M, et al. Treatment considerations for patients with neuropathic pain and other medical comorbidities. In: Mayo Clinic Proceedings. Elsevier, 2010. p. S15-S25. Go to original source...
    16. Dworkin RH, et al. Interventional management of neuropathic pain: NeuPSIG recommendations. PAIN(R), 2013, 154.11: 2249-2261. Go to original source...
    17. Rijsdijk M, et al. No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients. European Journal of Pain, 2013, 17.5: 714-723. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.